U.S., Nov. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07245641) titled 'Targeted Accelerated TMS for Post-Traumatic Stress Disorder' on Nov. 14.
Brief Summary: Post-traumatic stress disorder (PTSD) is a highly prevalent and debilitating condition among veterans and active-duty military personnel, with rates as high as 30% in certain combat-exposed populations. Conventional treatments such as prolonged exposure therapy and pharmacotherapy have limited efficacy and high dropout rates, highlighting the need for novel, rapidly effective interventions.
Transcranial magnetic stimulation (TMS) has been well established for treatment-resistant depression (TRD). Traditional TMS, which involves 6 to 7 weeks of d...